Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Psycheceutical logo — Groundbreaking biotech solutions for safer, more effective p...

Psycheceutical

Groundbreaking biotech solutions for safer, more effective psychedelic therapeutics.

Founded 2020 United States Fort Lauderdale, United States 4 employees Post-IPO Equity Total: $1.91M Biotechnology, Life Sciences +1

General Information

Company Name Psycheceutical
Founded Year 2020
Location United States Fort Lauderdale, United States
Employees 4
Industries Biotechnology, Life Sciences, Pharmaceutical
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Psycheceutical. To contact Psycheceutical, visit psycheceutical.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Psycheceutical compare?

A PDF of Psycheceutical and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Psycheceutical soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Psycheceutical

Psycheceutical is an innovative biotech company founded in 2020 in the United States. The company's slogan "Groundbreaking biotech solutions for safer, more effective psychedelic therapeutics" encapsulates its mission to revolutionize mental health treatments.

Specializing in Biotechnology and Pharmaceutical industries, Psycheceutical aims to overcome barriers in mental health care by leveraging patented delivery technologies to provide safe and effective psychedelic pharmaceutical medicines.

The company's recent investment of $1.30M in Post-IPO Debt, received on 01 June 2023, from Cantheon Capital underscores its potential and the confidence it commands from the investment community.

Psycheceutical's focus on advancing therapeutic solutions in the field of psychedelic medicine makes it a compelling and forward-thinking investment prospect in the biotech and pharmaceutical sectors.

Business keywords: Biotech, Psychedelic medicine, Drug delivery technology, Pharmaceuticals, Therapeutics, Medical innovation, Patented technology, Mental health treatment, Innovative medication, Medical advancements

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $100.00K -
02 Jul 2024
Post IPO Debt $1.30M 1
Cantheon Capital
01 Jun 2023
Seed Round $100.00K -
14 Mar 2022
Seed Round $405.00K -
12 Oct 2021

Psycheceutical Alternatives & Competitors

View All Alternatives
Psycheceutical vs
LinXis Biopharmaceuticals
LinXis Biopharmaceuticals The Netherlands

We target the cells that drive fibrosis

21 employees
Biotechnology, Health Care
Psycheceutical vs
Finopotamus
Finopotamus United States

Fintech News for Hungry CUs

Venture round
4 employees
Biotechnology, Health Care
Psycheceutical vs
Apidel
Apidel

Revolutionizing Therapeutics through Cutting-Edge Drug Delivery Solutions

Series C
Biotechnology, Pharmaceutical
View all alternatives

FAQ About Psycheceutical

Groundbreaking biotech solutions for safer, more effective psychedelic therapeutics.
Psycheceutical was founded in 2020.
Psycheceutical is headquartered in Fort Lauderdale, United States.
Psycheceutical operates in Biotechnology, Life Sciences and Pharmaceutical. Its work centres on Biotech, Psychedelic medicine, Drug delivery technology and Pharmaceuticals.
Psycheceutical has approximately 4 employees.
Psycheceutical has completed 4 funding rounds, raising a total of $1.91M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Psycheceutical include LinXis Biopharmaceuticals, Finopotamus, Apidel, Awakn Life Sciences, Procavea Biotech. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Psycheceutical and LinXis Biopharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Psycheceutical, https://bouncewatch.com/company/psycheceutical, updated 2 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes